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Abstract
Neuropathic pain resulting from nerve lesions or dysfunction represents one of the most challenging neurological diseases
to treat. A better understanding of the molecular mechanisms responsible for causing these maladaptive responses can
help develop novel therapeutic strategies and biomarkers for neuropathic pain. We performed a miRNA expression profiling
study of dorsal root ganglion (DRG) tissue from rats four weeks post spinal nerve ligation (SNL), a model of neuropathic
pain. TaqMan low density arrays identified 63 miRNAs whose level of expression was significantly altered following SNL
surgery. Of these, 59 were downregulated and the ipsilateral L4 DRG, not the injured L5 DRG, showed the most significant
downregulation suggesting that miRNA changes in the uninjured afferents may underlie the development and
maintenance of neuropathic pain. TargetScan was used to predict mRNA targets for these miRNAs and it was found
that the transcripts with multiple predicted target sites belong to neurologically important pathways. By employing
different bioinformatic approaches we identified neurite remodeling as a significantly regulated biological pathway, and
some of these predictions were confirmed by siRNA knockdown for genes that regulate neurite growth in differentiated
Neuro2A cells. In vitro validation for predicted target sites in the 39-UTR of voltage-gated sodium channel Scn11a, alpha 2/
delta1 subunit of voltage-dependent Ca-channel, and purinergic receptor P2rx ligand-gated ion channel 4 using luciferase
reporter assays showed that identified miRNAs modulated gene expression significantly. Our results suggest the potential
for miRNAs to play a direct role in neuropathic pain.
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Introduction
Neuropathic pain arises from nerve damage or dysfunction,
adversely impacting quality of life and imposing a large healthcare
burden [1,2,3]. A deeper understanding of the molecular
mechanisms underlying neuropathic pain could provide a first
step toward the development of better treatment options for
patients. A frequently used rat model to study the molecular
mechanisms of neuropathic pain is spinal nerve ligation (SNL)
wherein one or more spinal nerves innervating the hind limb are
ligated [4], typically unilaterally. The injury, which results in
hyperalgesia, an enhanced response to mechanical stimuli, has a
well-characterized time course. Since they represent a primary site
for pain processing, dorsal root ganglion (DRG) neurons have
been the focus of much research to identify molecular targets of
pain neurotransmission. Previous studies using animal pain models
have measured mRNA levels by examining a targeted set of
transcripts or through the use of global approaches such as
microarray technology to study mRNA expression changes [5,6].
In a proteomic study, 67 proteins have been shown to be regulated
in the SNL model [7].
MicroRNA (miRNA), a class of ,22 nucleotide, non-protein
encoding endogenous RNA molecules, has attracted considerable
attention recently for its role in the molecular changes underlying
various disease models [8]. miRNAs participate in the regulation
of gene expression by binding to the 39 untranslated region (39-
UTR) of target mRNAs, which can result in reduced expression of
the proteins encoded by such target RNAs. Reduction of protein
expression can come about by either of two mechanisms, the
cleavage and degradation of the mRNA target or repression of its
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inverse correlation between miRNA and target mRNA expression
is expected. Each miRNA species regulates multiple genes, and
most mRNAs contain multiple miRNA binding sites within their
39-UTR, suggestive of a complex regulatory network [9]. Since
aberrant miRNA expression is a common feature in a variety of
human diseases, an understanding of the gene regulation events in
neuropathic pain mediated by miRNAs could provide an avenue
for the identification of biomarkers or discovery of novel
therapeutic targets [8]. We performed a miRNA expression
profiling study of DRG 4 weeks following SNL surgery. A
combination of bioinformatics and experimental approaches,
including comparison to mRNA microarray profiling performed
on the same biological samples, were applied to identify biological
functions affected by the observed changes in miRNA expression.
Results
The SNL model has been used widely to investigate
neuropathic pain mechanisms and as an assay for the development
of new analgesic drugs. Ligation of spinal nerve results in long-
lasting behavioral signs of mechanical hyperalgesia and tactile
allodynia. Here we used the ligature of L5 (Figure 1a) and tested
for tactile allodynia to confirm the success of the surgery in
eliciting a pain response (data not shown).
MicroRNA data quality assessment, normalization and
statistical analysis
L4 and L5 dorsal root ganglia were collected from the ipsi- and
contralateral sides of SNL and sham-operated rats. A Taqman
Low Density Array (TLDA) miRNA expression profiling study was
performed on RNA extracted from these DRG samples. Heatmap
representation of sample to sample correlations shows a distinct
separation of all L4 ipsilateral samples from the L4 and L5
contralateral samples, which are not separated from each other.
The SNL L5 ipsilateral samples lie in between. Absence of
separation of the samples in the sham group indicates no
systematic effect of sham surgery on miRNA levels in this group
(Figure 1b).
Normalization of the miRNA dataset was performed using the
11 most rank-preserving miRNAs across all 40 samples (Figure
S1). The plot of normalized CT distributions (Figure 1c) again
shows a pattern that is consistent with the heatmap display: a very
distinct grouping of L4, and to a lesser degree L5 ipsilateral DRGs
from the SNL cohort from each other and from the rest of the
samples. These patterns indicate that this pain model resulted in
SNL-specific changes in miRNA expression levels, suggestive of an
SNL- injury driven alteration in the underlying molecular biology
of the DRGs.
A statistical analysis of the miRNAs that were differentially
expressed in L4 DRG samples was conducted by applying a filter
of p-value,0.01 and at least a 2-fold change in either direction.
This resulted in a list of 63 miRNAs (henceforth referred to as the
‘‘63-set’’) among the 365 miRNAs that were interrogated. A set of
10 microRNAs (the ‘‘10-set’’) appear to turn off their expression to
nearly undetectable levels in L4 ipsilateral DRGs, resulting in very
large expression fold changes (up to ,900 fold). Table 1 lists the
63-set miRNAs along with their p-values and signed fold changes
(signFC) for L4 and L5 segments, which shows mostly downreg-
ulation of miRNA expression in ipsilateral L4 DRGs. Although
the SNL effects on miRNA expression are more profound in the
L4 DRG samples, 45 members of the 63-set meet the criteria for
being differentially expressed in L5 as well.
In vitro validation using a reporter assay
After the identification of the 63-set of miRNAs, we examined
whether DRG-expressed genes can be targeted by these miRNAs.
For our studies we chose Cacna2d1, Scn11A or Nav1.9, and P2rx4,
each of which is well established in the neuropathic pain literature
[10,11,12,13,14]. The mRNA data for these genes from our
microarray expression profiling is shown in Table S1-A. A
luciferase reporter assay was used to determine the effect of
miRNA on gene function. HEK293 cells were co-transfected with
synthetic miRNA and a luciferase reporter construct consisting of
a3 9-UTR cloned downstream of the luciferase open reading
frame. We selected miRNAs from our 63-set with high-scoring
miRBase and TargetScan predictions towards the 3 selected target
genes (Table S1-B). Our results show that for each luciferase
reporter construct, at least one miRNA produced a significant
suppression of activity (Figure 2). For Scn11a and Cacna2d1, the
maximal suppression of gene expression was approximately 40%,
and a reduction by approximately 50% was observed for P2rx4
demonstrating that the 39-UTRs of these genes can be targets for
63-set miRNAs, implying a potential role for these miRNAs in
regulating DRG gene expression. Note that we achieved
experimental validation in our luciferase reporter assay only for
those miRNAs predicted through the TargetScan algorithm, while
those miRNAs predicted through only mirBase showed no
significant changes in luciferase activity (Table S1-B and
Figure 2). This observation is in line with other reports that
describe a better predictive power of TargetScan compared to
other common algorithms [9].
Prediction of miRNA targets and pathway analysis
To explore the likely biological consequences of SNL-mediated
miRNA expression changes, we identified mRNA transcripts
containing predicted target sites for these 63-set miRNAs. Since
predicted sites of any one miRNA can number in the hundreds
[15,16], it was necessary to reduce these numbers to a manageable
and biologically meaningful size. We used the TargetScan
algorithm [15] for our predictions due in part to our earlier
successes in predicting target gene modulation. Applying more
stringent context score cutoffs increases the likelihood of observing
biologically relevant effects when miRNAs are exogenously added
in vitro [17]. For the predicted target sites of the 63 miRNAs, we
applied a context score filter above the 60
th percentile, which
reduced the number to 10,751 predicted target sites in 4899 rat
genes.
Multiple miRNA target sites within a 39-UTR suggest that
miRNAs act together to orchestrate the modulation of mRNA
translation [17,18,19,20,21]. Figure 3 shows that there are
hundreds of transcripts containing multiple predicted 63-set target
sites. Note that the number of 63-set target sites on a single
transcript is not simply driven by 39-UTR length (Table S2).
Transcripts with few predicted 63-set target sites may be
functionally diverse, while those with a larger number of sites
may be more likely to be important to, and part of, a network of
biologically relevant response genes regulated by these miRNAs in
this pain model. To test this, we created 3 lists of target genes
having a successively increasing number of predicted 63-set target
sites (3 or more, 4 or more, and 5 or more which contained 1328,
697 and 382 genes, respectively) and then asked if requiring more
63-set target sites leads to an enrichment of gene functions relevant
to this model, i.e. the nervous system.
These 3 sets of target genes were imported into the Ingenuity
Pathway Analysis (IPA) tool to identify biological activities based
upon the underlying literature derived annotation. Figure 4 (panels
A to C) shows functions ranked by IPA’s negative log p-value,
MicroRNA Profiling in Rat Neuropathic Pain Model
PLoS ONE | www.plosone.org 2 March 2011 | Volume 6 | Issue 3 | e17670signifying overrepresentation of genes relevant to the described
function. Interestingly, with an increasing requirement for multiple
target sites the tissue-specific listing ‘‘Nervous System Develop-
ment and Function’’ rises through the ranking of functions, from
11
th to 2
nd position. This suggests that the TargetScan predicted
gene targets and our filtering approach enriched for neurological
events and functions. For a list of all genes with 3 or more
predicted target sites, see Table S3.
Closer examination of the subcategories of ‘‘Nervous System
Development and Function’’ shows neurogenesis and branching of
neurites as the top functional categories (additional details are
shownintheSupportinginformationfortablelistingsunderFigure4
and Table S4). Randomly chosen gene lists of comparable sizes
were analyzed in the IPA tool and demonstrate substantially lower
negative log p-values in these same functional categories. (Panel D,
Figure 4). An overlapping set of 153 transcripts emerges when the
1328 predicted 63-set target mRNAs (3 or more sites with a
TargetScan context score of 60th percentile) were compared to the
1806 differentially expressed messenger RNA transcripts identified
in a SNL-L4 ipsilateral versus contralateral comparison. These
genes were subjected to IPA Core Analysis (direct interactions,
only). The third and sixth ranking functions are ‘‘Neurological
Disease’’ and ‘‘Nervous System Development and Function,’’
respectively, both with significant p-values. Consistent with the
findings above, the top subfunctions under ‘‘Nervous System
Development and Function’’ include the growth and development
of neurites (Panel E, Figure 4).
We used SigPathway for differential expression studies at the
miRNA target level. The bioinformatic prediction algorithm
picTar [19] was used to map miRNAs to their target mRNA,
Figure 1. Profiling of miRNAs in DRG. a. Schematic representation of spinal L5 nerve ligation adapted from Decosterd and Woolf
(Pain, 2000). Individual L4 and L5 DRG tissue samples were collected from the ipsi- and contralateral sides of 5 sham (no ligature) surgery and 5 SNL
surgery rats four weeks after SNL for analysis. b. Pair-wise correlation of raw CT values among DRG samples. Heat map of sample-to-sample
(Pearson) correlation of raw CT values from 248 detectable miRNAs in 40 DRG samples from the 8 experimental groups. Column and row labels are
symmetric. c. Distribution of normalized CT values (DCT) in 40 samples. Each line represents CT distributions from one particular sample. The
color represents the experimental group. L4 and L5 ipsilateral DRGs in the SNL cohort (blue and black, respectively) are clearly separated from each
other and from the rest of the groups which appear to form an aggregate ‘group’ that contains all sham samples and all SNL contralateral samples.
The majority of data points (CT ranging from 29 to 39) in the blue curves are ‘‘shifted’’ to the right of the rest of the DRG sample distributions,
indicating a general down-regulation (hence higher CT) of miRNA expression in L4 ipsilateral DRGs of the SNL cohort.
doi:10.1371/journal.pone.0017670.g001
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miRNA
SNL L4 FC
(ips/con)
SNL L4 p-value
(t-test)
SNL L5 FC
(ips/con)
SNL L5 p-value
(t-test)
# Predicted
Targets
60th Percentile Context
Score
hsa-miR-221 2921.8 1.3E-07 21.3 9.9E-03 236 174
hsa-miR-34a 2604.4 1.0E-03 214.9 9.6E-04 409 269
hsa-let-7e 2337.7 1.4E-06 222.6 7.0E-03 758 403
hsa-miR-132 2234.1 6.0E-05 22.4 3.7E-02 232 151
hsa-miR-378 2185.7 1.1E-03 22.4 5.7E-02 84 57
hsa-miR-34c 2115.9 2.7E-04 22.6 4.6E-02 409 269
hsa-miR-409-5p 2104.4 7.0E-04 22.5 5.3E-02 70 43
hsa-miR-135a 265.8 2.1E-03 215.1 2.1E-02 426 253
hsa-miR-18a 235.6 7.7E-03 23.0 1.3E-01 139 110
hsa-miR-17-3p 216.2 2.4E-03 23.6 1.6E-01 165 119
hsa-let-7a 2459.7 2.8E-04 29.7 7.5E-06 758 403
hsa-miR-21 2382.2 2.6E-03 22.2 1.5E-04 167 112
hsa-miR-10b 2309.5 9.6E-04 28.5 4.8E-05 54 39
hsa-let-7d 2259.1 3.5E-03 25.8 4.1E-05 758 403
hsa-miR-93 2208.8 4.4E-03 22.4 4.5E-05 846 550
hsa-miR-20a 2177.7 3.4E-03 21.2 5.2E-02 846 550
hsa-miR-497 2132.0 7.1E-03 25.3 1.2E-03 936 528
hsa-let-7b 289.3 1.6E-06 25.9 3.0E-06 758 403
hsa-miR-10a 284.8 1.9E-04 24.8 1.6E-04 147 107
hsa-let-7c 280.7 3.8E-07 26.5 1.0E-05 758 403
hsa-miR-142-3p 269.0 5.7E-06 21.9 7.4E-04 217 152
hsa-miR-27b 258.1 3.6E-06 26.9 2.4E-07 792 524
hsa-let-7g 250.1 5.5E-05 24.9 1.6E-05 ** **
hsa-miR-301 245.3 1.6E-05 21.8 2.9E-04 576 353
hsa-miR-324-5p 239.8 6.3E-03 23.7 4.3E-05 55 38
hsa-miR-133a 224.6 3.8E-04 212.0 1.8E-05 429 228
hsa-miR-20b 221.3 8.5E-04 21.1 4.7E-01 846 550
hsa-miR-125b 219.4 1.2E-07 23.2 2.9E-08 520 337
hsa-miR-27a 216.0 3.3E-06 22.3 3.7E-05 792 524
hsa-miR-148b 215.6 1.9E-05 22.1 1.4E-03 437 319
hsa-miR-369-5p 215.5 1.8E-03 22.4 3.1E-03 5 3
hsa-miR-92 212.1 2.9E-05 21.3 1.5E-02 597 348
hsa-miR-181c 211.6 6.9E-03 22.3 1.7E-03 767 467
hsa-miR-100 29.6 8.3E-07 22.0 2.4E-05 37 28
hsa-miR-148a 28.5 5.9E-06 23.0 9.5E-06 437 319
hsa-miR-383 27.0 1.1E-03 23.7 1.7E-03 79 48
hsa-miR-9 27.0 4.2E-07 23.8 2.7E-05 892 501
hsa-miR-127 26.3 2.3E-06 21.7 1.5E-05 6 5
hsa-miR-26b 26.0 5.3E-06 22.0 5.4E-05 588 377
hsa-miR-30a-5p 25.9 4.1E-06 21.3 8.2E-03 1026 593
hsa-miR-142-5p 25.4 1.4E-03 1.0 8.7E-01 427 238
hsa-miR-30d 25.3 1.6E-06 6.5 4.1E-01 1026 593
hsa-miR-190 24.3 6.6E-03 24.2 1.6E-05 84 57
hsa-miR-19a 24.1 2.9E-06 1.7 1.2E-03 791 516
hsa-miR-23b 24.0 6.2E-05 23.8 1.8E-04 713 487
hsa-miR-339 23.9 3.0E-04 23.5 2.3E-02 83 49
hsa-miR-137 23.7 7.3E-06 25.3 7.0E-07 758 379
hsa-miR-181b 23.7 2.9E-04 22.0 6.3E-06 767 467
hsa-miR-19b 23.6 1.0E-04 1.7 8.3E-05 791 516
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altered in a transcriptional profiling of the same RNA samples
(data not shown; GEO accession number GSE24982). Targets for
51 of the 63 significantly changing miRNAs are predicted by
picTar and 18 of these 51 are changing at the target mRNA level.
However, there was no strict inverse correlation between miRNAs
of our 63-set and their corresponding mRNA targets (data not
shown).
Text-mining of miRNA associations with gene function
Text miningoftheexistingmiRNAliterature[22] combined with
the wealth of existing information on gene function was used to
predict biological outcomes due to our observed miRNA changes.
By text mining PubMed we could identify publications citing 61 of
the 63-set miRNAs (97%), only miRs-409-5p and -572 were
unpublished. Further mining of these miRNA-citing publications
for relationships between 63-set miRNAs and human genes
revealed 39 of the 63-set (60%) interacting with 153 human genes
(Table S5). We found 6 of the 10-set miRNAs interacting with 27
human genes. Interestingly, many of the genes interacting with the
10-set miRNAs are transcription factors. To determine whether
there is a functional relationship between the 63 miRNAs and pain,
we used the National Library of Medicine’s Medical Sub-heading
(MeSh) biomedical ontology to identify pain-related terms from our
text-mining of PubMed. By this method, only one miRNA (miR-
10A) could be linked to pain, reflectingthe lack of miRNA literature
in the pain field [23]. It is to be noted that miRNA research is a
rapidly expanding field and the list of genes and interactions are
constantly evolving with an increase in publications.
To investigate what biological processes are associated with the
153 miRNA-target set, we used DAVID (http://david.abcc.
ncifcrf.gov/) [24,25] to look for enrichment of functions within
the Biological Process section of the Gene Ontology (GO) [26].
DAVID clusters the list of enriched processes into functional
groups based upon associated ontological terms. Our analysis
showed that neurological processes were highly enriched for the
153 miRNA-target set genes (Table S6). DAVID identified several
enriched clusters containing broad neurological terms with
associated sub-categories that point to general neuronal remod-
eling processes, with recurring themes such as neurite/axon/
dendrite growth, differentiation and regulation. Given the
enrichment of neuronal remodeling processes observed in the
results from DAVID, we text-mined PubMed to search for
associations between these processes and the miRNA-target genes.
We identified 30 miRNA-target genes with known roles in neurite
or axon growth (Table S7) and curated the text-mined
miR:gene:neurite phenotype associations to predict neurite growth
outcomes in our model. The output from this analysis suggests that
down-regulating members of the 63-set miRNAs may increase
neurite outgrowth.
siRNA knockdown of predicted target genes
We investigated the neurite outgrowth functionality encoded by
presumptive target transcripts of 63-set miRNAs and were able to
support some of our predictions using data from an unrelated siRNA
screening project that analyzed genes by high content screening (HCS)
for their ability to regulate neurite growth in differentiated Neuro2A
cells (Figure S2). A gene whose knockdown by complementary siRNA
inhibited growth, would be considered a neurite outgrowth promoting
gene, and vice versa. We identified HCS data for 6 genes from our text
mining predictions. We observed that 5 out of 6 of the siRNA
inhibited genes affected neurite outgrowth in a manner that matched
our predictions, that is, inhibition of the specific target gene reduced
neurite growth (Table 2). This corroboration of several of our
predictions leads us to hypothesize that under normal conditions,
some of the miRNAs from the 63-set may act as repressors of neurite
miRNA
SNL L4 FC
(ips/con)
SNL L4 p-value
(t-test)
SNL L5 FC
(ips/con)
SNL L5 p-value
(t-test)
# Predicted
Targets
60th Percentile Context
Score
hsa-miR-126 23.3 3.2E-07 21.7 3.6E-05 16 10
hsa-miR-218 23.2 1.2E-05 21.0 3.8E-01 635 393
hsa-miR-181d 23.0 8.8E-04 21.3 1.2E-02 767 467
hsa-miR-335 22.7 6.2E-04 22.7 9.7E-05 121 88
hsa-miR-103 22.7 7.9E-05 22.0 2.1E-04 360 243
hsa-miR-26a 22.7 1.6E-05 21.5 2.2E-03 588 377
hsa-miR-299-5p 22.6 2.9E-03 21.3 4.2E-02 129 68
hsa-miR-572 22.6 6.2E-03 23.4 6.5E-03 ** **
hsa-miR-659 22.5 1.2E-03 22.2 7.1E-02 ** **
hsa-miR-338 22.3 2.9E-04 23.0 5.5E-04 154 100
hsa-miR-486 2.1 1.0E-03 21.6 2.6E-03 ** **
hsa-miR-30a-3p 2.5 6.1E-04 1.4 1.0E-03 ** **
hsa-miR-206 4.3 3.9E-05 1.3 1.3E-02 511 338
hsa-miR-133b 4.6 1.1E-06 10.2 7.3E-05 429 228
The set of 63 miRNAs found to be most differentially expressed in L4 ipsilateral DRGs of the SNL cohort compared to their contralateral counterpart. The set was derived
based on the filters of t-test p-value,0.01 (FDR,2%) and fold change (at least two fold in either direction). The majority of these miRNAs were down-regulated in the
ipsilateral relative to the contralateral DRGs, including the set of 10 miRNAs (bold type, top section of the table) whose expression level was almost undetectable in L4
ipsilateral DRGs (see text). The table was sorted by signed fold change (FC) for SNL L4. Bold type numbers indicate at least 2 fold up- or down-regulation in ipsilateral
relative to contralateral DRGs. Number of mRNA transcripts containing predicted target sites for these 63-set miRNAs based on TargetScan predictions is shown. For
increasing the stringency of the predicted target sites of the 63 miRNAs, we applied a context score filter above the 60
th percentile.
**No prediction from TargetScan database.
doi:10.1371/journal.pone.0017670.t001
Table 1. Cont.
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the observed down-regulation of these miRNAs.
Predicted Pathways from mRNA expression
Since we were also interested to see if pathways predicted to be
regulated by miRNA changes are also implicated through their
messenger-RNA changes we subjected SNL-regulated mRNA
transcripts to Ingenuity Pathway Analysis. Functions and diseases
(as defined in IPA) filtered for a nervous system context with a
minimum of 10 genes per category and significantly perturbed in
the SNL L4-specific DRG mRNA expression profiling dataset
(FC.+/21.5 & p-value,0.001) are shown in Figure 5. These
belong to the top scoring ‘‘Neurological Disease’’ category (rank 1
with p-value range 5.73E-09 to 2.87E-02) and ‘‘Nervous System
Development and Function’’ category (rank 22 with p-value range
3.36E-04 to 3.20E-02) relative to a total of 72 Ingenuity defined
broad function and disease categories. Development and growth of
neurites, neuropathy, and neuronal apoptosis are some of the
dysregulated functional processes in the SNL L4 DRGs.
Discussion
We report here miRNA changes in the SNL model of
neuropathic pain, adding this to the growing list of conditions
for which dysregulation of miRNA has been reported [27] (http://
www.mir2disease.org/). We have demonstrated SNL induced
miRNA changes in both L4 and L5 DRG, but the number of
miRNAs affected, as well as the magnitude of the changes, were
larger in L4 DRG. In the SNL model, tight ligation of the L5
spinal nerve results in ectopic activity not only in the injured L5
afferents, but in uninjured ipsilateral L4 afferents as well. Ectopic
activity in both L4 and L5 suggests the possibility that the two
populations of afferents are each capable of initiating and
maintaining the behavioral changes resulting from nerve injury.
Several studies support the hypothesis that these SNL-induced
changes are initiated and maintained by activity originating from
the injured afferents [28,29]. The alternative or uninjured/intact
afferent hypothesis suggests that changes in the uninjured and not
the injured afferents may underlie the development and
Figure 2. Luciferase reporter gene assay to assess the effect of miRNA on gene function. The effect of miRNA on gene regulation was
monitored by co-transfecting 100 nM miRNA and the luciferase reporter gene. The 39-UTR of Scn11a (Nav1.9), Cacna2d1and P2rx4 were cloned
downstream of the luciferase open reading frame. In addition to miRNAs that could bind to the corresponding UTR, negative control pre-miRNA was
transfected with the corresponding luciferase reporter plasmid for each gene analyzed. The luciferase activity was measured 24 hrs after transfection
and the ratio of firefly:renilla luciferase is expressed as percentage of control 6 standard deviation shown. A statistically significant difference from
control miRNA was calculated using one-way ANOVA and p-value of ,0.003 are represented by * in the figure.
doi:10.1371/journal.pone.0017670.g002
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while the injured L5 DRG plays a crucial role in the early stages of
injury, the uninjured L4 DRG may be playing a key role in the
later stages [33].
After nerve injury, inflammatory mediators and aberrant
neuronal activity set in motion transcriptional and posttransla-
tional changes resulting in the induction and maintenance of
neuropathic pain [34,35,36]. Molecular mechanisms contributing
to peripheral and central sensitization in chronic pain have so far
been studied only at the mRNA and protein levels. Pain model
studies have measured mRNA levels by either looking at a targeted
set of transcripts or through the use of global approaches such as
microarray technology to study changes in neuropathic pain. In
rat, 122 genes associated with the peripheral axotomy model for
pain have been reported [5]. Prominent among the biological
processes identified by pathway analysis in another study,
performed two weeks after SNL, were functions such as neurite
outgrowth and neuronal development, suggesting these effects to
be among the primary consequences of SNL injury [37]. In a
proteomic study [7], 67 proteins were found to be regulated seven
days after SNL surgery. Proteins responsible for multiple cellular
mechanisms such as structural and functional integrity of neurons
were found to be regulated. One issue not addressed in these
earlier studies is whether SNL-sensitive changes in mRNA or
protein expression are preceded by changes in the expression of
regulatory molecules such as miRNA.
Our miRNA profiling has identified a set of SNL-sensitive
miRNAs and indicates that most of these were down-regulated
following neuropathic injury. The resulting pattern was a clear
separation of the ipsilateral L4 and L5 experimental groups from
contralateral and sham-operated samples, which combine to
compose a homogeneous group. This separation among the
experimental groups was apparent before data normalization and
was retained afterward. We employed a novel approach to miRNA
normalization using a set of rank-preserved miRNAs with minimal
fluctuation across all treatment groups. This method minimizes the
potential bias that comes from the use of so-called housekeeping
miRNAs or other small RNAs. Our observed changes in miRNA
levels are greater than the SNL-associated mRNA changes [5,6], a
result which might suggest that the miRNA changes we observe
propagate their effects on protein levels through translational
regulation rather than through targeted mRNA degradation.
Our investigation of the biological consequences of SNL-
induced miRNA changes combined experimental and bioinfor-
matics approaches. By expressing the 39-UTR sequence from
three genes known to be expressed in DRG with certain SNL-
regulated miRNAs, we demonstrated the potential for an impact
of miRNA expression on target gene function. However, the large
number of SNL-regulated miRNAs identified (hundreds) and their
potential mRNA targets (thousands) prevented a comprehensive
assessment of all possible miRNA/target interactions. To reduce
the number of SNL-regulated miRNAs to a workable number, we
imposed statistical filters (p,.01 and .2-fold change in expres-
sion), generating what we term the 63-set of SNL-regulated DRG
miRNAs. Using published algorithms to predict target transcripts
for these miRNAs, we identified putative target transcripts of the
63-set, which were in turn subjected to pathway analysis.
In light of the known mechanisms of miRNA influence on gene
expression, itis not surprising that we didnot observe a strict inverse
correlation between the differentially regulated miRNAs and their
predicted mRNA targets in our profiling studies. Our observation
was a general down-regulation of miRNAs in our miRNA-profiling
and a general upregulation of mRNAs in our transcriptional
profiling studies. This pattern suggests that at least some of the
down-regulated 63-set miRNAs could have acted through a
transcriptional mechanism. Thus in addition to the classic switch
interactions where miRNA induction results in the downregulation
of preexisting mRNA targets, other types of interactions described
as tuning and neutral are also possible [9,38]. A large scale
proteomics study performed to investigate the influence of specific
miRNAs on protein levels revealed that hundreds of genes were
directly, but modestly, repressed by individual miRNAs [39,40].
Though many miRNA targets were affected by both repression of
translation and mRNA degradation, a number of targets were
predominantly regulated by translational repression [40]. Some
were repressed without detectable changes in mRNA levels. In
addition, transcription factors were some of the other major classes
of genes that are perturbed by SNL in the L4 DRG in our study and
could play an important role in gene regulation following SNL. It is
also interesting to note that expression of several transcription
factors are known to be regulated by miRNAs [41,42]. In depth
analysis of individual genes and the mode of action of miRNAs
targeting them is needed for further elucidation of miRNA activity
on specific target mRNAs in neuropathic pain.
Figure 3. Distribution of predicted 63-set target sites in
individual transcripts. The TargetScan algorithm was used for
miRNA target prediction and there are hundreds of transcripts
containing multiple predicted 63-set target sites. We increased the
stringency for the predicted target sites of the 63 miRNAs by applying a
context score filter above the 60th percentile. This reduced the number
to 10,751 predicted target sites in 4899 rat genes.
doi:10.1371/journal.pone.0017670.g003
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affecting many target transcripts) makes it difficult to extract
individual miRNA/target transcript interactions likely obscuring
specific inverse correlations between the expression changes of
miRNAs and their targets. In addition, the TLDA provides an
incomplete survey of rat miRNAs. Any highly regulated miRNAs
propagating their effects through target degradation, but which
are not represented in the limited array, would be unavailable to
our measuring of any existing correlation. Perhaps of greater
importance, prediction of miRNA target sites is an evolving field.
Any errors in prediction of miRNA target sites would undermine
our ability to observe a correlation between miRNA and mRNA
expression. A much more detailed follow-on study of individual
genes and the miRNAs targeting them will be required to classify
the mode of miRNA regulation in neuropathic pain. miRNA
regulating target gene expression by altering the stability of the
transcript and/or interference with the translational process adds
another level of complexity that must be considered in dissecting
the complex cascade of events that follow nerve injury during and
after the development of chronic pain.
Rather than focusing on the individual miRNA-target interac-
tions, pathway analysis and text mining methodologies were used
to understand the biological functions and processes in pain. Much
evidence exists that miRNAs can act together to repress the
translation of their cognate mRNA targets [17,18,19,21,43,44].
Based on the expectation that the most profound downstream
effects of SNL-mediated miRNA changes might be evident in the
function of genes containing multiple miRNA targets, we
performed pathway analysis on subsets of putative target mRNAs
based on the number of predicted 63-set target sites per transcript.
‘‘Nervous System Development and Function’’ and its subcategory
‘‘Neurogenesis’’ are prominent in the pathway analysis output
when such constrained input lists are considered. Comparison of
genes common between the miRNA target site predictions (the
382 genes from the ‘‘5 or more list’’) and SNL-regulated mRNAs
(1806 transcripts found to significantly change in L4 DRG)
showed an overlap of 46 genes. This overlapping gene set was also
subjected to pathway analysis, with the result that Huntington’s
disease, neuropathy, and cell death of neurons are leading
categories under ‘‘Neurological Diseases’’ and neurite growth
Figure 4. Ingenuity Pathway Core Analysis functions. Analysis of gene transcripts which had three-or-more (Panel A), four-or-more (Panel B)
and five-or-more (Panel C), predicted 63-set target sites and a TargetScan context score above the 60
th percentile shown. The listed functions under
the graphics are from the category called ‘‘Nervous System Development and Function.’’ The functions are sorted by p-value and only rows having 10
or more molecules are shown. Controls (Panel D) of randomly chosen gene sets of comparable sizes to the five-, four-, and three-or-more gene sets
were also run through Ingenuity Pathway Core Analysis and appear in this Analysis Comparison. Only the top three broad categories are shown and
they are sorted by the five-or-more order of functions. Overlap (Panel E) between the L4 ipsi- vs. contralateral mRNA transcripts and predicted mRNA
targets of 63-set miRNA (60
th percentile) were run through Ingenuity Pathway Core Analysis. The top six functional categories are shown and the sub-
categories under ‘‘Nervous System Development and Function’’ are listed, sorted by p-value and only rows having 10 or more molecules are shown.
doi:10.1371/journal.pone.0017670.g004
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opment and Function.’’ Text mining provided a complementary
means of assessing function of the 63-set miRNAs and their
putative target transcripts. By text mining, only one of the 63-set
miRNAs has a published connection with pain, while many of the
putative target transcripts (a set of 153 genes that contain 3 or
Table 2. Selected genes targeted by siRNAs during differentiation of Neuro2a cells.
Gene Feature p-Value Percent change
siRNA1 siRNA2 siRNA3 siRNA1 siRNA2 siRNA3
Akt3 Neurite Avg Length 9.9E-03 1.2E-05 8.9E-01 20.10 20.37 20.01
Akt3 Branch Point Avg Count 8.6E-01 6.9E-06 1.6E-05 20.01 20.63 20.28
Akt3 Neurite Count 3.3E-01 2.5E-05 5.9E-03 20.02 20.36 20.09
Creb1 Neurite Avg Length 1.2E-02 4.0E-01 2.3E-04 20.08 20.05 20.19
Creb1 Branch Point Avg Count 7.1E-04 5.0E-02 3.9E-05 20.25 20.10 20.54
Creb1 Neurite Count 1.8E-04 4.2E-02 6.3E-04 20.14 0.04 20.14
Crk Neurite Avg Length 7.5E-09 2.3E-07 3.4E-10 20.45 20.29 20.29
Crk Branch Point Avg Count 5.3E-07 6.5E-06 1.7E-05 20.53 20.23 20.28
Crk Neurite Count 1.1E-05 3.2E-03 1.2E-02 20.21 20.09 20.05
Myc Neurite Avg Length 3.6E-04 4.5E-04 8.5E-09 0.19 0.20 0.68
Myc Branch Point Avg Count 2.4E-02 1.6E-05 1.8E-05 0.09 0.20 0.44
Myc Neurite Count 3.1E-01 3.5E-07 7.9E-06 20.02 20.15 20.12
Srf Neurite Avg Length 6.0E-01 1.1E-05 2.2E-07 0.03 20.17 20.44
Srf Branch Point Avg Count 8.0E-05 2.0E-08 1.4E-06 20.17 20.35 20.42
Srf Neurite Count 1.9E-01 2.2E-03 7.8E-01 20.03 20.07 20.01
Tnf Neurite Avg Length 3.4E-06 6.3E-05 5.3E-01 20.49 0.29 0.03
Tnf Branch Point Avg Count 6.6E-05 9.9E-01 3.0E-03 20.68 0.00 20.31
Tnf Neurite Count 5.4E-08 8.1E-01 1.3E-06 20.57 20.01 20.24
Genes were each targeted by 3 independent siRNAs as indicated. The features of average neurite length and neurite count were determined and are shown here. p-
values in comparison to non-targeting control siRNAs are reported. Statistically significant changes are highlighted in bold. Percent changes in the features in
comparison to the same negative controls are also reported with increases highlighted in bold and decreases in italics (changes ,.04 are not highlighted).
doi:10.1371/journal.pone.0017670.t002
Figure 5. Functional categories perturbed in the SNL L4 DRGs. Functional processes related to Nervous System Development and Function
with a minimum of 10 genes are indicated. The bars represent the negative (log p-value) and the orange data points indicate the number of genes for
the given functional category. P-values indicate the probability that the observed association between the described functional categories and the
SNL pain gene set is due to chance. The ratio indicates the percentage of genes in these functional categories that are found in the SNL pain gene set.
The ratio thus indicates the strength of the association, and the p-value measures the statistical significance. The horizontal line indicates a p-value of
0.05.
doi:10.1371/journal.pone.0017670.g005
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DRG) are associated with neuronal remodeling, a result that
reinforces the results of pathway analysis.
The bioinformatic and pathway analysis approaches we pursued
rely heavily on the current understanding of miRNA-mRNA
interactions, something which is undergoing continual refinement
within the miRNA research community. In contrast, text mining
of literature-based information relies on published miRNA to
mRNA target interactions, most of which have been confirmed
experimentally. Interestingly, the biological functions associated
with the set of genes identified by text mining as targets of our 63-
set miRNAs bear a striking similarity to those functions identified
by pathway analysis of the predicted target set. These separate
approaches independently provide support for the idea that the
identified miRNAs in our study play an important role in neuronal
remodeling, as reflected by target genes functioning in neurite or
axonal growth. Taken together, these findings suggest that neural
remodeling activities are strongly associated with the set of
transcripts that are among the most likely molecular targets of
SNL-regulated miRNAs.
Neurons of the peripheral nervous system have the capacity to
regenerate following injury. Regeneration (and the earlier
degeneration) may have a significant role in the positive symptoms
of pain resulting from nerve injury [45,46]. Functional integration
of peripheral and central nervous systems after nerve injury results
in complex reorganization of circuits and could cause maladaptive
changes resulting in pain, disesthesia, and hyperreflexia, all
symptoms witnessed after spinal cord injury. Because SNL is a
nerve injury model, it should not be surprising that, in our
profiling of SNL-induced changes in DRG, miRNAs targeting
genes involved in neurite outgrowth and axonal regeneration
[47,48] are downregulated. Extending our studies of miRNAs
changes from the DRG to spinal cord would help us to better
understand the larger role of these miRNAs in neuropathic pain. A
recent study employing microarray analysis identified a set of
miRNAs altered in spinal cord injury [49]. Eight of the miRNAs
downregulated on day 7 were also downregulated in our studies.
In a separate study, 12 miRNAs were reported to be enriched in
mouse spinal cord. Of these twelve, eight are present in our 63-set
with two being upregulated and 6 down regulated [50].
An experimental connection between putative 63-set targets and
neurite outgrowth was derived from an independent siRNA survey
of neurite outgrowth. In a high content screen of siRNAs for their
ability to modulate neurite outgrowth in Neuro2A cells, six of the
siRNAs screened were specific to members of the putative target
gene set (the 153 genes mentioned above). In five of six cases,
siRNA reduced neurite outgrowth, an outcome consistent with
stimulation of neurite growth following downregulation of an
miRNA targeting the same transcript. It should be pointed out
that the HCS screen was performed independently of our profiling
study and thus provided an unbiased confirmation of the function
of these genes that were identified as putative miRNA targets.
Further experiments are needed to confirm the hypothesis that
miRNAs can play a role in suppressing neuronal remodeling.
In designing our studies, we chose to restrict our miRNA
profiling to a single tissue and a single time point. DRG was
chosen as the tissue for its well-documented role in pain signaling,
and 4 weeks post-SNL was chosen as the time point because this is
a time after the establishment of neuropathic pain. Consequently,
the kinetics of miRNA regulation is not investigated in this study.
Temporal regulation of mRNA expression in SNL is known
[5,6,37] and the same is likely true of miRNA expression [23,51].
A recent study, performed 2 weeks after SNL, focused on three
miRNAs that are expressed as a cluster (miR-96, -182, and -183)
in L5 DRG [52]. Significant downregulation was observed for
miR-96 and miR-183 in L5 DRG. These two miRNAs showed
altered expression in our study, but were excluded from our 63-set
because the L4 comparison did not meet the p,0.01 cutoff we
used in filtering the profiling output. In addition to differences in
time point at which the experiments were performed, Aldrich et al
used 4.5 S RNA as an endogenous control to normalize their data.
We used a more stringent and novel approach to miRNA
normalization using a set of rank-preserved miRNAs with minimal
fluctuation across all treatment groups. This normalization
method minimizes the potential bias that comes from the use of
so-called housekeeping miRNAs or other small RNAs [53]. Future
studies using tissues contributing to peripheral and central pain
(DRG, spinal cord and brain regions), at multiple time points and
in different pain models will be required for a full understanding of
the role miRNAs play in the development and maintenance of
chronic pain.
Our study provides an important first step toward understand-
ing SNL-sensitivity of miRNA expression and the possible gene
regulatory consequences of these expression changes. Additional
studies in neuropathic pain validating the role of individual
miRNAs, employing both cellular and in vivo miRNA delivery,
should further elucidate the functional roles for these miRNAs in
pain. Of equal benefit will be studies addressing the role of these
SNL-regulated miRNAs in neuronal degeneration and regenera-
tion. Of greatest importance, a better understanding of the
molecular consequences of nerve injury could provide a first step
toward development of novel therapies.
Methods
Spinal nerve ligation (SNL) model
Male Sprague–Dawley rats weighing 150–174 g were obtained
from Harlan Laboratories (Indianapolis, IN) and were housed
under controlled temperature and 12 h light/dark cycle for at least
6 days before any procedure. Food and water were provided ad
libitum. SNL injury, or sham operation, was performed according
to the procedure of Kim and Chung [4]. Briefly, under 2.5%
isoflurane in O2, the dorsal vertebral column was exposed and the
left L6 transverse process removed. The L5 spinal nerve was
isolated and tightly ligated distal to the dorsal root ganglia with a
4-0 silk suture. The incisions were then closed. Sham control rats
underwent the same operation and handling as the experimental
animals, but without nerve ligation. Postoperatively, rats were
housed individually under the same general conditions. All
procedures were approved by Wyeth’s Industrial Animal Care
and Use Committee. Rats (SNL and sham) were tested for tactile
sensitivity immediately prior to surgery (baseline) and before tissue
extraction 4 weeks post-surgery to ensure SNL rats were
hypersensitive. Tactile sensitivity was assessed by measuring each
rat’s paw withdrawal threshold in response to probing with von
Frey monofilaments (Stoelting, Wood Dale, IL) according to the
method of Chaplan et al. [54]. At week 4 after SNL or sham
surgery, rats were deeply anesthetized with ketamine HCl.
Bilateral L4 and L5 DRG’s were excised, immediately frozen in
dry ice and stored at 270uC.
Total RNA isolation
Individual DRG tissue samples were homogenized using an Omni
tissue homogenizer (TH) using Omni tip clear plastic homogenizing
p r o b e s( O m n iI n t e r n a t i o n a l ,M a r i e t t a ,G A ) .T o t a lR N Aw a sp u r i f i e d
from individual DRGs using the mirVana
TM miRNA Isolation Kit
(Ambion, Austin, TX) following the manufacturer’s instructions.
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Drop Technologies, Wilmington, DE).
Description and overview of human miRNA TLDA panel
A Taqman Low Density Array (TLDA) Human miRNA Panel
(rodent panel was not available at the time the experiments were
performed) (Applied Biosystems, Foster City, CA), was used for
measuring the expression levels of miRNAs expressed in rat DRGs
according to the manufacturer’s instructions. Bioinformatic miRNA
sequence comparisons confirmed a large overlap in miRNA sequence
between rat and human that allowed the use of a human miRNA
TLDA for miRNA expression profiling of these rat tissues. Using
strict standards, 57 of the rat miRNAs in the 63 set were found to be
identical to the human sequence on the ABI array. Using only the
human sequences on the ABI array, a total of 169 rat miRNAs were
found to be identical to their human orthologs. Although this may
seem low, almost twice the number of human miRNAs have been
f o u n dc o m p a r e dt or a t .C o m p a r e dt om o u s e ,o n l y6 4 %o ft h er a t
miRNAs have been identified. Contributing reasons for the number
discrepancy may be the incomplete rat genome (there are many
gaps), and the attention given to human and mouse as model
organisms for miRNA studies.Listing of miRNAs that areidentical in
human and rats are shown in Table S11.
cDNA synthesis
Following the manufacturer’s instructions, miRNAs were
reverse transcribed from total RNA using the TaqMan Micro-
RNA Reverse Transcription Kit in conjunction with the Multiplex
RT for TaqMan MicroRNA Assay pools (both Applied Biosys-
tems, Foster City, CA); each total RNA sample (derived from one
DRG) was divided into 8 fractions of 100 ng total RNA each and
converted into a 8 multiplex pools of cDNA.
TLDA TaqMan Real Time Assay
Following the manufacturers instructions for each multiplex RT
reaction a TaqMan master mix was prepared using Taqman
Universal PCR Master Mix (Applied Biosystems, Foster City, CA);
a final volume of 100 mL/port (which supplies the master mix to
48 individual wells) was loaded into each of the 8 ports/TLDA
card. TLDA cards were assayed on an ABI PRISM 7900
Sequence detector (Sequence Detector Software v2.2.2) using
universal thermal cycling conditions of 50uC for 2 minutes, 95uC
for 10 minutes, then 40 cycles of 95uC for 15 seconds and 60uC
for 1 minute. We adapted the instrument default procedures of
calculating relative quantification (RQ) to accommodate the multi-
factorial design of this experiment. For consistent miRNA
quantitation in all 40 samples, the threshold level for background
detection in SDS software was manually set to 0.2.
Statistical analysis design and rationale
A group of 10 animals was divided into 2 cohorts, (n=5) one
subjected to SNL injury and the other undergoing sham surgery.
Bilateral L4 and L5 DRGs were harvested from each cohort,
yielding a total of 40 samples for RNA isolation and TLDA
processing. Within the SNL cohort, comparison of ipsilateral
DRG (on the same side of the surgery) to the contralateral DRG
provides an estimate of the combined ‘‘treatment’’ effect of SNL-
induced pain effect (which is the effect of interest) plus any
background effect that would be induced by surgery alone. This
pure surgical effect can be considered an experimental artifact and
therefore should be removed from the combined treatment effect.
The estimation of this effect was achieved by the ipsilateral versus
contralateral DRG comparison in the sham group.
Data quality assessment and filtering
miRNA CT values from all TLDA plates were collected and CT
distributions on each plate were inspected for data variability and
sample anomalies. To reduce noise in the data for subsequent
analysis, CT readings flagged by instrument as ‘‘undetectable’’
(CT=40) were removed from the data set. The remaining 248
miRNAs were used for downstream analysis.
Normalization
To investigate the issue of normalization, we first examined the
endogenous controls on the TLDA card. Of the 3 controls only
RNU6B was detected in the majority of DRG samples. Figure S1
shows the variation of CT for RNU6B as well as the mean and
median CT calculated from all the detectable miRNAs on each
TLDA plate. As shown in the figure, RNU6B closely follows the
variation of mean and median plate CT across the sample range
which is driven by biological and experimental conditions.
Because of lack of duplication wells for RNU6B located in an
edge column, it is difficult to determine whether the CT variation
in RNU6B across the samples was due to plate-to-plate variation
or random noise alone. Normalizing by plate mean or median CT
will result in ‘‘cancelation’’ of much of the biological variations.
We sought an alternative normalization approach, based on the
idea of choosing a minimal rank difference or rank-invariant
miRNA set from within the data, a strategy commonly employed
in microarray analysis [55]. Specifically, we identified a set of 11
detectable miRNAs on the TLDA card to serve as a
normalization reference. The expression ranking of these
miRNAs was minimally perturbed across the 40 samples (Figure
S1). To normalize data, we first calculated the mean CT values of
all 11 miRNAs to derive a single reference profile as
normalization baseline (plotted pink in Figure S1). Then, we
subtracted the mean control miRNA CT from the raw CT of each
miRNA on the same TLDA plate. These normalized expression
had the same unit as DCT, and were used subsequently for
differential expression analysis (Table S8).
Statistical analysis
Because DRGs from both sides of L4 and L5 are from the same
animals, a paired t-test was performed per miRNA to compare the
ipsi- and contralateral DRGs within each segment in the SNL
cohort, followed by false discovery rate (FDR) adjustment for
multiple testing [55]. The same analysis procedures were also
performed in the sham cohort. Signed fold changes were
calculated using the standard formula, 2
2DDC
T, to convert the
DD CT obtained from the paired t-test into a linear scale, followed
by taking the negative reciprocal of the fractional fold change. As
described in the statistical design section, to obtain the SNL-
specific pain effect, the treatment effect from the SNL cohort
analysis needs be adjusted by the surgery effect estimated from the
sham cohort. To perform the adjustment, we identified miRNAs
with significant (FDR,5%) changes in expression in the sham
comparison, and subtracted the fold change in the sham segment
from the fold change estimated for the corresponding SNL
segment. This procedure resulted in 4 (or 5) miRNAs whose fold
change in the L4 (L5 respectively) segment was adjusted and with
small magnitudes, suggesting overall surgery effect is largely
negligible.
Prediction of miRNA targets
The sequences of miRNAs were obtained from miRBase.
Predicted miRNA targets and their associated genes were obtained
from TargetScan and downloaded from the targetscan.org
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from Applied Biosystems. Conserved predicted miRNA target sites
identified with the TargetScan algorithm have context scores
based on the location within the 39-UTR, local AU composition at
that location, and base-pairing at the 3 prime (3P) end of the
miRNA. These scores were used to filter targets above the 60
th
percentile.
For TargetScan data mining purposes, the 63-set list of miRNA
names was modified to accommodate the differences in nomen-
clature between the ABI TLDA platform used to capture miRNAs
and the TargetScan database of predicted target sites. For
example, the miRNA designated as miR-10a by ABI is called
miR-10a-5p by TargetScan. In addition to nomenclature issues,
TargetScan groups paralogous miRNAs as having the same
predicted target sites. For example, miR-30a and miR-30d have
the same predicted target sites, so only miR-30a was used in our
analysis to avoid duplication of data. A complete list of naming
differences appears in the Table S9.
Gene symbols of transcripts with predicted target sites were used
to obtain the annotation from the Ingenuity Pathway Analysis tool.
Lists of these symbols were uploaded into the tool and Core
Analysis was run looking at direct relationships only. Functions
were examined and ranked by p-value.
mRNA expression profiling, data normalization and
filtering
Affymetrix rat genome GeneChips 430 2.0 were used for
mRNA profiling and data was normalized using the MAS 5
algorithm. GeneData Expressionist enterprise system (http://
www.genedata.com/products/expressionist.html) was used for
statistical analyses. A p-value of ,0.001 (FDR,1.5%) was used
as a cutoff after a t-test analysis to identify probesets that were
differentially expressed in the ipsi vs. contralateral L4 DRGs. FDR
calculation was performed according to the procedures of
Benjamini and Hochberg [56]. For the sham group 2101
probesets and for the SNL group 2239 probesets were identified.
Of these differentially expressed probesets, 1806 probesets were
specific to the SNL L4 DRGs.
The accession number for data deposited in Gene Expression
Omnibus (GEO) is GSE24982.
mRNA pathway analysis
Pathway analysis was performed using Ingenuity Pathways
Analysis (IPA) (Ingenuity Systems, Redwood City, CA) and
MetaCore (GeneGo; www.genego.com). A fold change of 1.5
was imposed on the 1806 probesets that are differentially
expressed and specific to the SNL L4 DRGs. Transcription factor
networks were built in MetaCore. Networks around known
miRNA targets were built in IPA and MetaCore and significance
of various GO categories and functional processes was analyzed
for these miRNA-target networks. Interactome analysis was done
in MetaCore.
Identifying miRNA morphological variants
The most common miRNA morphological variants were
identified following term-frequency analysis of a training set of
full-text miRNA review articles. Curated regular expression
patterns were developed to identify as many miRNAs as possible.
Accuracy of regular expressions was tested by querying a
download of annotation data from miRBase (http://microrna.
sanger.ac.uk/sequences/ftp.shtml). Once acceptable accuracy and
recall were achieved, regular expression patterns were imported
into I2E for text-mining.
Text-mining
All text-mining was performed using the I2E indexing/semantic
search tool (Linguamatics, UK). Experimental literature corpuses
used for text-mining were PubMed (NLM) and a set of
approximately 3000 miRNA-citing full-text journal articles.
Sentences containing miRNAs were identified using curated
regular expression patterns. Semantic relationships were retrieved
using the I2E’s linguistic rules in combination with subject-specific
dictionaries and ontologies. Dictionaries to identify human genes
were derived from Entrez Gene (ftp://ftp.ncbi.nlm.nih.gov/gene/
). Cellular processes were identified using the MeSH ontology
(http://www.nlm.nih.gov/mesh/).
Luciferase reporter gene assay
Plasmids for biological validation of miRNAs were constructed
as follows. The 535 bp 39-UTR of Scn11a (Nav1.9) (accession
number NM_019265), 389 bp 39-UTR of Cacna2d1 (accession
number NM_012919) and 710 bp 39-UTR of P2rx4 (accession
number NM_031594) were synthesized with Pme1 and Xho1
restriction enzymes sites at the 59 and 39 ends respectively. The
UTR fragments were then cloned into the pmirGLO Dual-
Luciferase miRNA target expression vector (Promega, Madison,
WI) and sequenced for confirmation. Lipofectamine 2000
mediated transfections of HEK293 cells in suspension were
performed using 1 mg plasmid DNA and 100 nM of individual
premiRNA. Fifty ml of cells (20,000cells/well) were plated in 96
well tissue-culture treated polystyrene black clear flat-bottom assay
plates (BD Biosciences, San Jose, CA). Plates were maintained at
37uC in a humidified atmosphere containing 5% CO2. The
functional assay for measuring firefly and renilla luciferase activity
was done 24 hours after transfection according to manufacturer’s
protocol.
siRNA screening of predicted target genes
UndifferentiatedmouseNeuro2Acells(N2A)were maintained by
regular passage in a growth medium consisting of Minimal Essential
Medium with 10% FBS, 0.1 mM non-essential amino acids, 2 mM
GlutaMax-1, and 1 mM sodium pyruvate (all from Invitrogen,
Carlsbad, CA).Cells were transfected with custom designed siRNAs
(Ambion, Austin, TX) via a reverse transfection procedure with
Optifect (Invitrogen) following the manufacturer’s recommended
procedure. Briefly, 2 ml of each siRNA at a concentration of 1 mM
was spotted into four independent wells of a 384-well dish and
stored at 280uC until use. Three independent siRNAs per gene
were spotted giving a total of twelve independent wells per gene per
plate. N2Acells weredetached from growth plates using trypsinand
then resuspended in Opti-MEM I medium (Invitrogen) at a
concentration of 50 cells/ml. Fifty nanograms of an EGFP
expression plasmid (Clontech, Mountain View, CA) along with
0.5 ml of Optifect were then added per 20 ml of resuspended cells
and plated (final 1000 cells/well). Cells were maintained overnight
and the next day, switched to a differentiation medium consisting of
growth medium with reduced FBS (2% final) and 8 mM retinoic
acid (Sigma, St Louis, MO). Cells were maintained in this medium
for four days then fixed with 4% paraformaldehyde. After fixation
cells were labeled with rabbit anti-GFP (Novus, Littleton, CO) to
detect transfected cells and mouse monoclonal anti-TuJ1 (Covance,
Emeryville, CA) to detect differentiated cells. Anti-rabbit and anti-
mouse secondary antibodies conjugated respectively with AF488 or
AF594 (Invitrogen) were used for visualization. Nuclei were
counterstained with Hoechst33258. Images of stained cells were
captured using a Cellomics ArrayScan HCS Reader (Thermo
Fisher Scientific, Pittsburgh, PA). Each well was fully scanned in
threeexcitation/emissionchannels;475/535(green),535/590(red),
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surviving cells per well was set as a lower limit. Images were
processed using the Neuronal Profiling V.2 software application
(Thermo Fisher) to quantify cell shape and process size parameters
of cells staining positive in the red channel (TuJ1+). Images were
gated such that only transfected (green) cells were considered in the
analysis. The assay was repeated three times and a percent
difference from the average of negative control siRNA transfected
cells was calculated for each reported parameter. Negative control
siRNAs (RISC-free siRNA #4390843 (Ambion) and NegsiRNA
#1022076 (Qiagen, Valencia, CA) were also spotted into four
independent wells each. siRNAs sequences are shown in Table S10.
The data analysis workflow was executed as follows. A set of 48
cytological parameters describing the morphological features of
cells (e.g. cell body, nucleus, neurites) were extracted from the
Cellomics database. These features were summarized at the well
level by the Cellomics image analysis software Neuronal Profiling.
After data quality inspection, plate-level normalization was
performed using the control wells as the baseline. Normalized
feature data were log2-transformed and the Student t-test was
applied to each feature to compare siRNA transfection readout
with the negative control. The test procedure was iterated for each
siRNA (3 per gene) for all genes. ‘‘Gene hits’’ were identified for
further evaluation based on statistical significance of knockdown
effect (p-value,0.01 in at least 2 siRNAs per gene) plus relevant
biological criterion such as percent difference above certain
threshold (.25% in at least 2 siRNAs per gene).
Supporting Information
Figure S1 Assessment of CT distribution of various
controls for normalization. Group-specific mean and median
CT for RNU6B (endogenous control) show a parallel trend of variation
as the plate-specific mean and median CT of the set of 248 detectable
miRNAs (excluding RNU6B). Thiss u g g e s t st h a te x p e r i m e n t a l
variation may have been confounded with the biological variation.
On average, the set of 11 rank-preserving (see text) miRNAs shows a
reduced variation and was chosen as the normalization reference.
(TIFF)
Figure S2 Example images of differentiated Neuro2a
cells. Cells transfected with negative control non-targeting siRNA
(B, D) or siRNA targeting Crk. Green cells in C and D have taken
up a co-transfected GFP plasmid and therefore indicate siRNA
transfected cells. Note the neuritis protruding from green cells in D
and the diminished size protruding from green cells in C. A and B
show the same respective images of C and D with cell traces
applied.
(TIFF)
Table S1 A. Transcriptional profiling (mRNA) data for
P2rx4, Cacna2d1 and Nav1.9. Each t-test comparison is
between the ipsilateral versus the contralateral side (uncorrected p-
values are shown). Cacna2d1 is upregulated, Nav1.9 (Scn11a) shows
significant downregulation only in the SNL L5 DRG and P2rx4 is
not regulated significantly. B. miRNA prediction using
TargetScan and mirBase for Cacna2d1, Nav1.9 and
P2rx4. Length of the 39-UTR for these genes and fold change
of the miRNAs in L4 and L5 DRG are also shown.
(DOC)
Table S2 A sampling of the lengths of 39-UTRs used by
TargetScan in miRNA target prediction. Two sets of
sequences appear: those predicted to have 10 or more (N=14)
63-set target sites and 14 randomly chosen transcripts predicted to
have only one 63-set target site. The rows are sorted by 39-UTR
length and the unit of length is nucleotides.
(DOC)
Table S3 Rat transcripts possessing 63-set miRNA
target sites predicted by TargetScan. Predictions have
TargetScan context scores above the 60th percentile. The rows are
sorted by the number of predicted 63-set miRNA target sites per
transcript. The multiple miRNA target sites listed for a gene are
ordered by decreasing TargetScan context score. Gene annotation
provided by the Ingenuity Pathway Analysis tool.
(XLS)
Table S4 Ingenuity Pathway Core Analysis. Analysis of
functions of 1328 genes with three or more predicted 63-set target
sites and a TargetScan context score above the 60
th percentile.
The listed functions are subcategories under the broader category
called ‘‘Nervous System Development and Function.’’ The rows
are sorted by p-value and lists with P-values of E-04 and lower are
shown.
(DOC)
Table S5 Text mining of miRNAs. 39 microRNAs (of the
63-set) and their literature associated human target genes (Entrez
gene symbols) uncovered from a systematic mining of PubMed.
Verb-group triplets were identified using regular expressions and a
gene thesaurus using the I2E semantic search tool. All entries in
bold represent the 10-set.
(DOC)
Table S6 Partial results from GSEA of 153 miRNA-
regulated genes against GO Biological Processes (DA-
VID).
(DOC)
Table S7 Neurite or axonal phenotypes regulated by the
63-set associated gene.
(DOC)
Table S8 Complete list of rank normalized CT values
for the 63-set miRNAs for all samples.
(XLS)
Table S9 microRNA nomenclature.
(DOC)
Table S10 siRNA sequences used in screening of
predicted target genes.
(XLS)
Table S11 Comparison of rat and human miRNAs.
(XLS)
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